Grufity logo
Grufity logo
UTRS

UTRS - Minerva Surgical, Inc. Stock Price, Fair Value and News

00
Market Closed as of 15 Jun 2026, 04:00 pm ET

Price Targets

00

UTRS Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

UTRS Price Action

UTRS RSI Chart

UTRS Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

UTRS Valuation

Market Cap

0

Price/Earnings (Trailing)

0

Price/Sales (Trailing)

0

EV/EBITDA

-0.83

Price/Free Cashflow

0

UTRS Price/Sales (Trailing)

The Good, Bad and Ugly

Growth

Profitability

Size

Dilution Risk

Balance Sheet

Momentum

Funds Popularity

Insider Trading

Price Targets

00

UTRS Fundamentals

UTRS Revenue

UTRS Earnings

UTRS Profitability

Free Cashflow Yield

0%

UTRS Investor Care

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs(opens in new tab)
Net sales
YearQ1Q2Q3Q4
202351.9M52.3M51.7M-
202251.2M50.1M50.1M50.3M
202141.4M44.9M48.5M52.1M
2020---37.8M
Get all data in R, Python etc through our Historical Stock Data APIs(opens in new tab)

About Minerva Surgical, Inc.

UTRS
Minerva Surgical, Inc., a commercial-stage medical technology company, develops, manufactures, and commercializes minimally invasive solutions to meet the uterine healthcare needs of women in the United States. The company provides Minerva ES Endometrial Ablation System and Genesys HTA Endometrial Ablation System, which are endometrial ablation devices; Symphion Tissue Removal System, a minimally invasive uterine tissue removal system to combine bladeless tissue resection and coagulation, continuous visualization, and intrauterine pressure monitoring; and Resectr Tissue Resection Device, a handheld surgical instrument to enable the hysteroscopic removal and diagnosis of endometrial polyps. Its devices are utilized by obstetrician-gynecologists in various medical treatment settings, including hospitals, ambulatory surgical centers, and physician offices. The company was incorporated in 2008 and is headquartered in Santa Clara, California.
 CEO
 WEBSITEhttps://minervasurgical.com
 SECTORHealthcare
 INDUSTRYMedical Devices
 EMPLOYEES174

Minerva Surgical, Inc. Frequently Asked Questions

UTRS is the stock ticker symbol of Minerva Surgical, Inc.. Every public company that trades on a stock exchange gets a ticker symbol.

As of Thu May 28 2026, market cap of Minerva Surgical, Inc. is 0. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

As of Thu May 28 2026, UTRS's PE ratio (Price to Earnings) is 0 and Price to Sales (PS) ratio is 0. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. UTRS PE ratio will change depending on the future growth rate expectations of investors.